tradingkey.logo
tradingkey.logo
Search

Can Fite Biopharma Ltd

CANF
Add to Watchlist
3.170USD
-0.110-3.35%
Close 07-31 16:00ETQuotes delayed by 15 min
27.67KMarket Cap
LossP/E TTM

CANF Financials

See Can Fite Biopharma Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Can Fite Biopharma Ltd Earnings Date

Latest Release
Mar 26, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
405.00K
-39.91%
EPS(YoY)
-1.79K
45.03%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q2
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2019Q4
FY2019Q3
Financial Indicators
EPS
----
----
----
----
----
----
70.00%-0.33
53.55%-0.43
49.44%-0.41
---0.65
---1.11
---0.93
---0.81
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
-21.32%155.00K
-3.92%196.00K
-3.92%196.00K
-4.39%196.00K
-3.43%197.00K
-18.73%204.00K
-18.40%204.00K
38.51%205.00K
36.00%204.00K
18.96%251.00K
--250.00K
--148.00K
-21.88%150.00K
-81.68%211.00K
----
--192.00K
--1.15M
Net Profit
----
----
----
----
----
----
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
54.99%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
-84.64%-6.71M
-32.04%-3.40M
---3.22M
---1.88M
24.06%-3.63M
12.65%-2.58M
----
---4.78M
---2.95M
Net Margin
----
----
----
----
----
----
30.45%-1065.81%
27.48%-898.98%
20.67%-852.04%
---1301.02%
---1532.49%
---1239.71%
---1074.02%
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
-21.32%155.00K
-3.92%196.00K
-3.92%196.00K
-4.39%196.00K
-3.43%197.00K
-18.73%204.00K
-18.40%204.00K
38.51%205.00K
36.00%204.00K
18.96%251.00K
--250.00K
--148.00K
-21.88%150.00K
-81.68%211.00K
----
--192.00K
--1.15M
Operating profit
----
----
----
----
----
----
40.51%-1.83M
27.52%-1.86M
13.82%-1.78M
-14.43%-2.71M
23.46%-3.08M
26.70%-2.57M
33.93%-2.07M
-9.17%-2.37M
-13.37%-4.03M
-41.59%-3.51M
---3.13M
---2.17M
22.95%-3.55M
11.18%-2.48M
----
---4.61M
---2.79M
Net Profit
----
----
----
----
----
----
45.28%-1.65M
30.33%-1.76M
23.78%-1.67M
-4.77%-2.55M
54.99%-3.02M
25.62%-2.53M
31.94%-2.19M
-29.61%-2.43M
-84.64%-6.71M
-32.04%-3.40M
---3.22M
---1.88M
24.06%-3.63M
12.65%-2.58M
----
---4.78M
---2.95M
Current assets
5.10%9.44M
30.82%7.62M
-9.35%8.98M
----
-46.58%5.83M
----
8.20%9.91M
-27.86%9.06M
-25.22%10.91M
-24.30%13.38M
-54.37%9.16M
-13.19%12.56M
52.72%14.59M
39.98%17.67M
113.49%20.07M
9.32%14.47M
-24.80%9.55M
--12.63M
31.58%9.40M
--13.24M
--12.70M
--7.14M
----
Total current liabilities
33.09%2.73M
6.69%2.12M
1.58%2.05M
----
-11.02%1.99M
----
-19.26%2.02M
-20.96%2.21M
3.72%2.23M
-0.45%2.89M
-8.35%2.50M
29.87%2.80M
-8.73%2.15M
41.04%2.90M
115.13%2.73M
18.36%2.15M
57.16%2.36M
--2.06M
-61.20%1.27M
--1.82M
--1.50M
--3.27M
----
Total assets
4.32%9.51M
30.36%7.72M
-8.70%9.12M
----
-46.32%5.92M
----
7.61%9.99M
-27.84%9.17M
-25.19%11.03M
-24.42%13.49M
-54.16%9.28M
-13.20%12.71M
52.33%14.75M
40.06%17.85M
112.67%20.25M
9.85%14.64M
-24.38%9.68M
--12.74M
16.50%9.52M
--13.33M
--12.80M
--8.17M
----
Total liabilities
6.46%3.92M
2.70%3.54M
-1.66%3.68M
----
-17.20%3.44M
----
-22.14%3.75M
-25.46%3.93M
-14.34%4.16M
-14.20%5.00M
-18.05%4.81M
-0.51%5.28M
-15.21%4.85M
2.81%5.82M
70.22%5.87M
40.16%5.30M
57.11%5.72M
--5.66M
-39.83%3.45M
--3.79M
--3.64M
--5.73M
----
Total equity
2.87%5.59M
68.78%4.18M
-12.93%5.44M
----
-63.94%2.48M
----
39.60%6.24M
-29.52%5.24M
-30.51%6.87M
-29.37%8.49M
-68.91%4.47M
-20.42%7.43M
150.11%9.89M
69.88%12.02M
136.78%14.38M
-2.17%9.33M
-56.80%3.96M
--7.08M
148.73%6.07M
--9.54M
--9.16M
--2.44M
----

FAQs

What is the total revenue of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its total revenue reached 405.00K, with a year-on-year change of 674.00K.

What are the current assets of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its current assets were 9.44M, with a year-on-year change of 5.10.

What are the total assets of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its total assets of Can Fite Biopharma Ltd were 9.51M, with a year-on-year change of 4.32.

What are the total liabilities of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its total liabilities of Can Fite Biopharma Ltd were 3.92M, with a year-on-year change of 6.46.

What is the total equity of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its total equity of Can Fite Biopharma Ltd was 5.59M, with a year-on-year change of 2.87.

What is the net operating income of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its net operating income of Can Fite Biopharma Ltd was -9.95M, with a year-on-year change of -22.39.

What is the net investment of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its net investment of Can Fite Biopharma Ltd was -2.00K, with a year-on-year change of -100.13.

What is the net financing of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its net financing of Can Fite Biopharma Ltd was 9.64M, with a year-on-year change of 43.70.

What is the Earnings Per Share (EPS) of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -1791.02, with a year-on-year change of 45.03.

What is the net income of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its net income was -9.83M, with a year-on-year change of -24.72.

What is the net margin of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its net profit margin was -2426.67, with a year-on-year change of -107.56.

What is the Return on Equity (ROE) of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its Return on Equity (ROE) was -178.24, with a year-on-year change of -32.08.

What is the Return on Assets (ROA) of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its Return on Assets (ROA) was -105.48, with a year-on-year change of -27.90.

What is the operating profit of Can Fite Biopharma Ltd?

According to Can Fite Biopharma Ltd's FY2025 earnings report, its operating profit was -9.95M, with a year-on-year change of -22.39.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.